05/31/2024 3:50 PM | Arcutis Biotherapeutics (Issuer) Burnett Patrick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/30/2024 2:39 PM | Arcutis Biotherapeutics (Subject) Burnett Patrick (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/29/2024 6:38 PM | Arcutis Biotherapeutics (Issuer) Matsuda Masaru (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/20/2024 4:12 PM | Arcutis Biotherapeutics (Issuer) Edwards Larry Todd (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/17/2024 2:58 PM | Arcutis Biotherapeutics (Subject) Edwards Larry Todd (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/14/2024 3:08 PM | Arcutis Biotherapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/14/2024 3:06 PM | Arcutis Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
05/02/2024 2:27 PM | Arcutis Biotherapeutics (Subject) Burnett Patrick (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/02/2024 2:28 PM | Arcutis Biotherapeutics (Subject) Matsuda Masaru (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/02/2024 2:29 PM | Arcutis Biotherapeutics (Subject) Moore Matthew Richard (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/02/2024 2:31 PM | Arcutis Biotherapeutics (Subject) Watanabe Todd Franklin (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/11/2024 7:30 PM | Arcutis Biotherapeutics (Issuer) Topper David Joseph (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
04/11/2024 7:32 PM | Arcutis Biotherapeutics (Issuer) Topper David Joseph (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/10/2024 3:15 PM | Arcutis Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/06/2024 4:12 PM | Arcutis Biotherapeutics (Issuer) Burnett Patrick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 4:14 PM | Arcutis Biotherapeutics (Issuer) Matsuda Masaru (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 4:08 PM | Arcutis Biotherapeutics (Issuer) Moore Matthew Richard (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 4:09 PM | Arcutis Biotherapeutics (Issuer) Watanabe Todd Franklin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 11:40 AM | Arcutis Biotherapeutics (Subject) Frazier Life Sciences VIII, L.P. (Filed by)
| Form SC 13D/A | |
03/06/2024 9:31 AM | Arcutis Biotherapeutics (Subject) JENNISON ASSOCIATES LLC (Filed by)
| Form SC 13G/A | |
03/04/2024 4:44 PM | Arcutis Biotherapeutics (Subject) OSBORNE DAVID W (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024 4:47 PM | Arcutis Biotherapeutics (Subject) Watanabe Todd Franklin (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024 4:38 PM | Arcutis Biotherapeutics (Subject) Burnett Patrick (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024 4:40 PM | Arcutis Biotherapeutics (Subject) Matsuda Masaru (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024 4:42 PM | Arcutis Biotherapeutics (Subject) Moore Matthew Richard (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2024 3:21 PM | Arcutis Biotherapeutics (Filer)
| Form 424B5 | |
02/27/2024 3:34 PM | Arcutis Biotherapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/27/2024 6:48 AM | Arcutis Biotherapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/27/2024 6:44 AM | Arcutis Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/15/2024 5:36 PM | Arcutis Biotherapeutics (Issuer) Burnett Patrick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 5:47 PM | Arcutis Biotherapeutics (Issuer) Moore Matthew Richard (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 5:23 PM | Arcutis Biotherapeutics (Issuer) Smither John W (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 5:30 PM | Arcutis Biotherapeutics (Issuer) Watanabe Todd Franklin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 5:32 PM | Arcutis Biotherapeutics (Issuer) Matsuda Masaru (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 3:19 PM | Arcutis Biotherapeutics (Subject)
| Form SC TO-I/A | |
02/15/2024 3:20 PM | Arcutis Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/13/2024 11:29 AM | Arcutis Biotherapeutics (Subject) SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
| Form SC 13G/A | |
02/13/2024 8:26 AM | Arcutis Biotherapeutics (Subject) Polar Capital Holdings Plc (Filed by)
| Form SC 13G/A | |
02/12/2024 8:52 AM | Arcutis Biotherapeutics (Subject) MORGAN STANLEY (Filed by)
| Form SC 13G | |
02/12/2024 5:06 AM | Arcutis Biotherapeutics (Subject) Rubric Capital Management LP (Filed by)
| Form SC 13G | |
02/08/2024 11:15 PM | Arcutis Biotherapeutics (Filer)
| Form EFFECT | |
Are You Positioned For The New Energy Goldrush? (Ad) Open AI’s Sam Altman recently helped this company raise $577 million in funding…
What’s more is, It has already inked deals with the Department of Energy. Click here to get all the information about it. |
02/08/2024 11:52 AM | Arcutis Biotherapeutics (Subject) JENNISON ASSOCIATES LLC (Filed by)
| Form SC 13G | |
01/31/2024 4:22 PM | Arcutis Biotherapeutics (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
01/29/2024 2:26 PM | Arcutis Biotherapeutics (Subject) BlackRock Inc. (Filed by)
| Form SC 13G | |
01/23/2024 9:26 AM | Arcutis Biotherapeutics (Subject) STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/17/2024 3:28 PM | Arcutis Biotherapeutics (Issuer) Moore Matthew Richard (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/17/2024 3:30 PM | Arcutis Biotherapeutics (Issuer) Watanabe Todd Franklin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/17/2024 3:32 PM | Arcutis Biotherapeutics (Issuer) Matsuda Masaru (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/17/2024 3:34 PM | Arcutis Biotherapeutics (Issuer) Edwards Larry Todd (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/17/2024 3:35 PM | Arcutis Biotherapeutics (Issuer) Burnett Patrick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/16/2024 5:03 AM | Arcutis Biotherapeutics (Subject)
| Form SC TO-I | |
01/03/2024 4:30 PM | Arcutis Biotherapeutics (Issuer) Burnett Patrick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/02/2024 1:29 PM | Arcutis Biotherapeutics (Subject) Burnett Patrick (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/22/2023 4:24 PM | Arcutis Biotherapeutics (Issuer) Watanabe Todd Franklin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/22/2023 2:26 PM | Arcutis Biotherapeutics (Subject) Turney Patricia A. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/18/2023 5:33 AM | Arcutis Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/01/2023 7:51 PM | Arcutis Biotherapeutics (Issuer) Watanabe Todd Franklin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/29/2023 2:51 PM | Arcutis Biotherapeutics (Subject) Burrows Scott L (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/21/2023 4:47 PM | Arcutis Biotherapeutics (Issuer) Matsuda Masaru (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/21/2023 2:36 PM | Arcutis Biotherapeutics (Subject) Matsuda Masaru (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/16/2023 12:13 PM | Arcutis Biotherapeutics (Subject) Polar Capital Holdings Plc (Filed by)
| Form SC 13G | |
11/13/2023 8:02 AM | Arcutis Biotherapeutics (Subject) FMR LLC (Filed by)
| Form SC 13G/A | |
11/09/2023 1:54 PM | Arcutis Biotherapeutics (Subject) PRUDENTIAL FINANCIAL INC (Filed by) PRUDENTIAL FINANCIAL INC (Filed by)
| Form SC 13G | |
11/07/2023 2:33 PM | Arcutis Biotherapeutics (Subject) BlackRock Inc. (Filed by)
| Form SC 13G/A | |
11/03/2023 6:32 AM | Arcutis Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/03/2023 6:36 AM | Arcutis Biotherapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/23/2023 3:23 PM | Arcutis Biotherapeutics (Filer)
| Form 424B5 | |
10/23/2023 3:25 PM | Arcutis Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/19/2023 3:02 PM | Arcutis Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/19/2023 3:15 PM | Arcutis Biotherapeutics (Filer)
| Form 424B5 | |
10/03/2023 8:45 PM | Arcutis Biotherapeutics (Issuer) Edwards Larry Todd (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/03/2023 8:41 PM | Arcutis Biotherapeutics (Issuer) Edwards Larry Todd (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
09/27/2023 3:30 PM | Arcutis Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/15/2023 3:07 PM | Arcutis Biotherapeutics (Filer)
| Form 10-K/A | |
09/15/2023 3:08 PM | Arcutis Biotherapeutics (Filer)
| Form 10-Q/A | |
09/15/2023 3:09 PM | Arcutis Biotherapeutics (Filer)
| Form 10-Q/A | |
09/12/2023 6:39 AM | Arcutis Biotherapeutics (Issuer) Moore Matthew Richard (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/07/2023 5:48 AM | Arcutis Biotherapeutics (Filer)
| Form 8-K/A | |
09/05/2023 8:36 PM | Arcutis Biotherapeutics (Issuer) Smither John W (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
09/05/2023 8:38 PM | Arcutis Biotherapeutics (Issuer) Smither John W (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/22/2023 11:24 AM | Arcutis Biotherapeutics (Issuer) Burnett Patrick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/21/2023 9:58 AM | Arcutis Biotherapeutics (Subject) Burnett Patrick (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/18/2023 3:32 PM | Arcutis Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/15/2023 3:31 PM | Arcutis Biotherapeutics (Subject) Lock Kenneth A. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2023 4:22 PM | Arcutis Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/02/2023 8:36 PM | Arcutis Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/02/2023 7:31 PM | Arcutis Biotherapeutics (Issuer) Matsuda Masaru (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/02/2023 6:16 PM | Arcutis Biotherapeutics (Issuer) Heron Patrick J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/02/2023 6:22 PM | Arcutis Biotherapeutics (Issuer) LIN SUE-JEAN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/02/2023 5:54 PM | Arcutis Biotherapeutics (Issuer) Welgus Howard G. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/02/2023 5:59 PM | Arcutis Biotherapeutics (Issuer) Krishnamohan Neha (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
SHOCKING Crypto Leak… (Ad) A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products.
If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE…
The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
Claim your free seat by clicking here now. |
06/02/2023 6:02 PM | Arcutis Biotherapeutics (Issuer) Leonard Keith R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/02/2023 6:08 PM | Arcutis Biotherapeutics (Issuer) Gilbert Halley E (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/02/2023 6:10 PM | Arcutis Biotherapeutics (Issuer) Curran Terrie (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/02/2023 6:13 PM | Arcutis Biotherapeutics (Issuer) CHAUDHURI BHASKAR (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |